Tirzepatide - A New Weight Loss Medication
- Rise Up Health
- Mar 5, 2023
- 2 min read
Updated: Mar 23
Tirzepatide is a promising new drug for weight loss that has recently been approved by the US Food and Drug Administration (FDA) for the management of Type 2 Diabetes and is fast tracked to be approved for weight loss. Tirzepatide is a once-weekly injectable medication that has been shown to help people lose weight and improve their overall health.
In this blog post, we'll take a closer look at tirzepatide and what you need to know before considering taking it for weight loss.
What is Tirzepatide?
Tirzepatide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by stimulating the release of insulin in response to high blood sugar levels, which helps to regulate blood sugar levels and prevent diabetes. It also reduces appetite and slows down the rate at which food is absorbed in the stomach.
The drug was developed by Eli Lilly and Company, and has been approved by the FDA for the treatment of type 2 diabetes and obesity. In clinical trials, tirzepatide has been shown to be more effective for weight loss than other GLP-1 receptor agonists, such as Semaglutide.
How does Tirzepatide work for weight loss?
Tirzepatide works by reducing appetite and slowing down the rate at which food is absorbed in the stomach. It also increases the rate at which the body burns fat, which can lead to weight loss.
In clinical trials, tirzepatide was shown to be effective for weight loss in people with obesity. In a study published in the New England Journal of Medicine, participants who took tirzepatide lost an average of 14.9% of their body weight, compared to 2.4% for those who took a placebo. The study also found that tirzepatide was effective for improving other health markers, such as cholesterol levels.
Here is the link to schedule a free consult call with our provider
Comments